Jiuzhitang Co Ltd - Asset Resilience Ratio
Jiuzhitang Co Ltd (000989) has an Asset Resilience Ratio of 12.97% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Jiuzhitang Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Jiuzhitang Co Ltd's Asset Resilience Ratio has changed over time. See 000989 net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Jiuzhitang Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiuzhitang Co Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥648.00 Million | 12.97% |
| Total Liquid Assets | CN¥648.00 Million | 12.97% |
Asset Resilience Insights
- Moderate Liquidity: Jiuzhitang Co Ltd has 12.97% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Jiuzhitang Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiuzhitang Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Huadong Medicine Co Ltd
SHE:000963 |
Drug Manufacturers - Specialty & Generic | 0.05% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
Drug Manufacturers - Specialty & Generic | -2.56% |
|
Celltrion Pharm Inc
KQ:068760 |
Drug Manufacturers - Specialty & Generic | 12.49% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
Annual Asset Resilience Ratio for Jiuzhitang Co Ltd (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Jiuzhitang Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 5.76% | CN¥300.00 Million ≈ $43.90 Million |
CN¥5.21 Billion ≈ $762.60 Million |
+1.42pp |
| 2023-12-31 | 4.34% | CN¥231.20 Million ≈ $33.83 Million |
CN¥5.33 Billion ≈ $779.92 Million |
-1.60pp |
| 2020-12-31 | 5.94% | CN¥301.39 Million ≈ $44.10 Million |
CN¥5.07 Billion ≈ $742.12 Million |
-5.34pp |
| 2019-12-31 | 11.29% | CN¥553.58 Million ≈ $81.01 Million |
CN¥4.90 Billion ≈ $717.72 Million |
+7.87pp |
| 2018-12-31 | 3.41% | CN¥179.16 Million ≈ $26.22 Million |
CN¥5.25 Billion ≈ $767.94 Million |
+1.71pp |
| 2017-12-31 | 1.70% | CN¥100.00 Million ≈ $14.63 Million |
CN¥5.87 Billion ≈ $859.51 Million |
+1.64pp |
| 2010-12-31 | 0.06% | CN¥1.03 Million ≈ $150.35K |
CN¥1.74 Billion ≈ $254.40 Million |
0.00pp |
| 2009-12-31 | 0.06% | CN¥936.29K ≈ $137.01K |
CN¥1.55 Billion ≈ $226.45 Million |
-8.49pp |
| 2008-12-31 | 8.56% | CN¥132.28 Million ≈ $19.36 Million |
CN¥1.55 Billion ≈ $226.26 Million |
+7.85pp |
| 2007-12-31 | 0.70% | CN¥10.10 Million ≈ $1.48 Million |
CN¥1.44 Billion ≈ $210.96 Million |
-0.21pp |
| 2006-12-31 | 0.91% | CN¥12.56 Million ≈ $1.84 Million |
CN¥1.37 Billion ≈ $200.95 Million |
-5.04pp |
| 2005-12-31 | 5.95% | CN¥77.61 Million ≈ $11.36 Million |
CN¥1.30 Billion ≈ $190.72 Million |
+5.39pp |
| 2004-12-31 | 0.57% | CN¥7.61 Million ≈ $1.11 Million |
CN¥1.34 Billion ≈ $196.01 Million |
-0.29pp |
| 2003-12-31 | 0.86% | CN¥11.53 Million ≈ $1.69 Million |
CN¥1.34 Billion ≈ $195.70 Million |
+0.47pp |
| 2002-12-31 | 0.39% | CN¥3.95 Million ≈ $578.07K |
CN¥1.02 Billion ≈ $149.12 Million |
-- |
About Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more